Table 3.
Comparison between the characteristics of the COVID-19 and pneumonia groups.
| Characteristics | COVID-19 | Pneumonia | p-value |
|---|---|---|---|
|
Sample size n, % |
432 100% |
711 100% |
|
|
Gender n, % |
0.0001 | ||
| Female |
150 35% |
320 45% |
|
| Male |
282 65% |
391 54.99% |
|
|
Age Mean (sd) Median |
66.97 (13.07) 68 |
73.14 (13.68) 78 |
|
|
Age group n, % |
0.0001 | ||
| < 50 |
44 10.19% |
49 6.89% |
|
| 50–59 |
69 15.97% |
51 7.17% |
|
| 60–69 |
120 27.78% |
141 19.83% |
|
| 70–79 |
128 29.63% |
199 27.99% |
|
| ≥ 80 |
71 16.44% |
271 38.12% |
|
| Comorbidities | |||
| Hypertension |
162 37.50% |
181 25.46% |
0.0001 |
| Obesity |
56 12.96% |
63 8.86% |
0.03 |
| Diabetes mellitus type I |
12 2.78% |
5 0.70% |
0.01 |
| Diabetes mellitus type II |
75 17.36% |
145 20.39% |
0.21 |
| Dialysis |
43 9.95% |
4 0.56% |
0.0001 |
| Chronic kidney disease |
43 9.95% |
88 12.38% |
0.21 |
| Supraventricular tachyarrhythmia |
25 5.79% |
201 28.27% |
0.0001 |
| Congestive heart failure |
12 2.78% |
204 28.69% |
0.0001 |
| COPD |
24 5.56% |
72 10.13% |
0.01 |
| Heart failure |
29 6.71% |
27 3.80% |
0.03 |
| Kidney failure |
26 6.02% |
4 0.56% |
0.0001 |
| Respiratory failure |
19 4.40% |
88 12.38% |
0.0001 |
| Cerebral ischaemic stroke |
28 6.48% |
– | 0.0001 |
In bold the p-values that reached the statistical significance.